Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo-controlled, Proof of Concept Trial to Investigate the Efficacy and Safety of Intra-articular 4P004 in Subjects With Knee Synovitis and Osteoarthritis
Conditions
Interventions
4P004
Placebo (NaCl 0.9%)
Locations
22
United States
Tucson Orthopaedic Institute
Tucson, Arizona, United States
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
Skylight Health Research Burlington
Burlington, Massachusetts, United States
Durham Bone and Joint Specialists
Ajax, Canada
SJHC London Rheumatology Centre
London, Canada
G.R.M.O. (Groupe de recherche en maladies osseuses) Inc
Québec, Canada
Start Date
June 17, 2025
Primary Completion Date
July 1, 2026
Completion Date
September 1, 2026
Last Updated
April 14, 2026
NCT06755697
NCT07351968
NCT06747494
NCT07036003
NCT06906939
NCT07224958
Lead Sponsor
4Moving Biotech
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions